Thereby, NEAT1 inhibition could offer a novel therapy to treat NASH.277 In addition, by inhibiting the MAPK signalling pathway, the lncRNA HULC may exacerbate the pathogenesis of NAFLD by promoting the progression of hepatic fibrosis and hepatocyte apoptosis.278. The gene discussed is NEAT1; the disease is metabolic dysfunction-associated steatohepatitis.